The Miconazole 2% Oral Gel is a specially formulated antifungal medication intended for the treatment of oral thrush (candidiasis) and other fungal infections within the oral cavity. This unique liquid formulation is designed to be delivered as a spray, allowing for easy and direct application to the affected areas within the nasal cavity. The spray form ensures that the medication can provide targeted local effects, combating the fungal infection at the site. While primarily used for its local action, the medication can also have systemic effects due to the rich vascular supply in the nasal area. This formulation is particularly useful for patients who have difficulty swallowing or prefer a spray to traditional oral gels.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Miconazole 2% Oral Gel is a specially compounded medication designed to treat fungal infections within the oral cavity and can be adapted for use in the nasal cavity. This antifungal agent works by disrupting the cell membrane of the fungus, leading to the death of the fungal cell. The formulation is prepared as a liquid that is administered via a spray, allowing for easy and targeted application to the nasal mucosa. This delivery method is particularly beneficial for treating localized fungal infections in the nasal passages and can also provide systemic effects as the medication is absorbed through the nasal mucosa into the bloodstream.
The use of Miconazole in a nasal spray form is an off-label application, as it is traditionally used for oral thrush and other mucocutaneous fungal infections. However, its efficacy in treating nasal fungal infections, such as those caused by Candida species, has been recognized. The 2% concentration ensures that a sufficient dose of the medication is delivered directly to the site of infection, maximizing the therapeutic effect while minimizing systemic absorption and potential side effects.
For patients, it is important to understand that this formulation should be used as directed by a healthcare provider, and it is essential to adhere to the prescribed dosing schedule to ensure the best possible outcome. Patients should be aware of potential side effects, which may include local irritation or allergic reactions. For prescribers, considering the patient's medical history and current medications is crucial to avoid potential drug interactions and contraindications.
As compounding pharmacists at Bayview Pharmacy, we are committed to providing high-quality, customized medications to meet the unique needs of our patients. We are available to answer any questions and provide guidance on the use of this Miconazole 2% Oral Gel formulation for nasal administration. If you have any questions or require further information, please do not hesitate to reach out to us.
Miconazole is an antifungal agent commonly used to treat fungal infections. When formulated as a 2% oral gel and delivered via a nasal spray, it is important to consider potential drug interactions, as the nasal cavity provides a direct route for drug absorption into the systemic circulation. This can lead to both local and systemic effects. Patients should be aware that the use of miconazole in any form can interact with certain medications, potentially altering their effects.
One significant interaction is with warfarin, an anticoagulant. Miconazole can inhibit the metabolism of warfarin, leading to an increased risk of bleeding. Patients on warfarin should have their blood clotting status closely monitored, and dosage adjustments may be necessary. Similarly, miconazole may enhance the effects of other anticoagulants and antiplatelet drugs, increasing the risk of bleeding complications.
Patients taking oral hypoglycemic agents, particularly sulfonylureas such as glipizide or glyburide, should be monitored for signs of hypoglycemia, as miconazole can potentiate their effects. This interaction may necessitate a dosage adjustment of the hypoglycemic agent by the prescriber.
Miconazole may also interact with certain statins metabolized by the CYP3A4 enzyme, such as simvastatin and atorvastatin. This interaction can increase the risk of myopathy and rhabdomyolysis. Patients using these statins should be advised to watch for symptoms such as muscle pain or weakness and report them immediately to their healthcare provider.
Additionally, miconazole can inhibit the metabolism of certain benzodiazepines, cyclosporine, tacrolimus, and some calcium channel blockers, potentially leading to increased plasma concentrations and enhanced or prolonged effects. This may require dose adjustments and careful monitoring of therapeutic and adverse effects.
Patients using other topical nasal products or those with a history of nasal issues such as chronic rhinitis or recent nasal surgery should consult with their healthcare provider before using miconazole nasal spray, as there may be additional considerations regarding the safety and efficacy of the treatment.
It is crucial for patients to inform their healthcare providers of all medications they are currently taking, including over-the-counter drugs, herbal supplements, and vitamins, to avoid potential drug interactions. Prescribers should review the patient's medication profile for any possible interactions before prescribing miconazole nasal spray and continue to monitor the patient throughout the treatment course.
For more detailed information on drug interactions with miconazole 2% oral gel in nasal spray form or for any other inquiries, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure appropriate treatment for our patients.
Miconazole is an antifungal agent that belongs to the class of drugs known as azoles. It works by inhibiting the synthesis of ergosterol, a critical component of fungal cell membranes. Without ergosterol, the cell membrane becomes permeable and leaks essential intracellular components, leading to the death of the fungus. Miconazole 2% Oral Gel in a liquid formulation delivered as a nasal spray is an innovative approach to treat fungal infections localized in the nasal cavity or to provide systemic effects through the highly vascularized nasal mucosa.
The nasal spray formulation is designed to deliver a fine mist of the medication, ensuring that the active ingredient, miconazole, is distributed evenly throughout the nasal passages. This targeted delivery system allows for direct action on the affected area, which can be particularly beneficial for treating local fungal infections within the nasal cavity. The nasal route of administration also has the advantage of bypassing the gastrointestinal tract, which can be useful in patients with malabsorption issues or those who have difficulty swallowing oral medications.
When administered nasally, the miconazole spray can provide a rapid onset of action due to the rich blood supply in the nasal mucosa, which can facilitate the absorption of the drug into the systemic circulation. This can be advantageous for treating certain systemic fungal infections. However, the primary intention of this formulation is to exert its effect locally within the nasal passages. The formulation has been designed to minimize systemic absorption and maximize local exposure to the antifungal agent.
For patients and prescribers considering the use of Miconazole 2% Oral Gel nasal spray, it is important to understand that this formulation is intended for the treatment of fungal infections within the nasal cavity, such as those caused by Candida and other susceptible fungi. It is not typically used for common nasal conditions like allergic rhinitis or viral infections. Proper diagnosis of a fungal infection by a healthcare professional is essential before using this medication.
As with any medication, it is crucial to follow the prescribed dosing regimen and to use the nasal spray correctly to ensure the effectiveness of the treatment. Patients should be instructed on the proper technique for administering the nasal spray to ensure that the medication is delivered effectively to the site of infection. Additionally, patients should be advised to report any adverse effects or signs of systemic absorption, such as nausea or dizziness, to their healthcare provider.
If you have any questions or require further information about the Miconazole 2% Oral Gel nasal spray formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
Miconazole is an antifungal medication principally known for its action against a wide variety of fungal infections. While the 2% oral gel formulation you referenced is specifically designed for managing oral thrush, it's important to note that when repurposed as a nasal spray, miconazole retains its antifungal properties and therefore could potentially be utilized off-label for the treatment of certain fungal infections in the nasal cavity. Fungal sinusitis is an example where targeted application via a nasal spray could provide direct relief, although this is not a conventional use and would need to be done under the guidance of a healthcare professional.
Furthermore, due to the formulation's mucosal delivery system through the nasal cavity, it could theoretically afford a more systemic absorption of the miconazole. This could potentially offer implications for the treatment of certain systemic fungal infections where appropriate miconazole blood levels are indicated. Nevertheless, since this is not the primary intention of the formulated product and systemic absorption can vary, it is essential for healthcare providers to monitor patient response and safety if using it for systemic purposes.
In addition to its antifungal action, miconazole has also demonstrated in vitro activity against certain gram-positive bacteria, suggesting that there may be a potential role for this formulation in the management of nasal bacterial overgrowth or infections. However, such use would be considered highly experimental and off-label, requiring the consultation of an infectious disease specialist.
Finally, the anti-inflammatory properties of miconazole could be beneficial in reducing nasal inflammation, although there are limited studies to support this, and alternative treatments with more established efficacy and safety profiles are available.
Given the unconventional applications of miconazole nasal spray discussed, it is paramount that these other uses are thoroughly evaluated in partnership with a healthcare professional. Patients or prescribers considering this formulation for any off-label use should proceed with caution and consult a pharmacist or doctor before doing so. If you have any questions regarding this formulation and its potential applications, please don't hesitate to reach out to us at Bayview Pharmacy for further assistance. We're here to ensure safety and efficacy in all your pharmacotherapy needs.
Miconazole 2% Oral Gel is a liquid formulation designed to be delivered in a spray form, specifically for administration into the nasal cavity. Although commonly known as an oral gel for treating oral fungal infections, in this formulation, it is intended for use via the nostrils to provide targeted local or systemic effects against fungal infections within the nasal passages.
To use the Miconazole nasal spray, gently insert the tip of the spray bottle into one nostril, close the other nostril with your finger, and press the pump to deliver the medication. Inhale gently while spraying. Repeat the process for the other nostril if directed. Use it according to the prescribed dose and frequency recommended by your healthcare provider.
The safety of Miconazole 2% Oral Gel nasal spray in children has not been established without consulting a healthcare provider. It is essential to consult a pediatrician before using this medication in children to ensure proper dosage and to assess if it is an appropriate treatment option for their condition.
No, this specific formulation of Miconazole 2% Oral Gel is designed for nasal administration and should not be used for oral thrush. Oral thrush treatment requires a different formulation intended for application inside the mouth. Always follow your healthcare provider's instructions and use medications as prescribed for their intended use.
As with any medication, there can be side effects. Common side effects of Miconazole nasal spray may include nasal irritation, burning, sneezing, or a runny nose. If you experience any severe reactions or symptoms persist, contact your healthcare provider.
The frequency of use for Miconazole 2% Oral Gel nasal spray will be determined by your healthcare provider based on your medical condition and response to treatment. It's important to follow the prescribed regimen and not to exceed the recommended dosage.
It will not be effective for bacterial or viral sinus infections. If you suspect you have a sinus infection, consult with a healthcare professional to determine the cause and appropriate treatment.
If you are pregnant or breastfeeding, you should consult with a healthcare provider before using Miconazole 2% Oral Gel nasal spray. They will assess the benefits and potential risks to determine whether it is safe for you to use during pregnancy or while breastfeeding.
If you miss a dose of Miconazole 2% Oral Gel nasal spray, use it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not use double doses to make up for the missed dose.
Store Miconazole 2% Oral Gel nasal spray at room temperature away from light and moisture. Keep the container tightly closed when not in use. Always keep medications out of reach of children and pets. Dispose of any expired or unused medication properly as per local guidelines or consult with your pharmacist for disposal instructions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale intranasally